ROYAL BANK OF CANADA

Bank

Position in LENZ — LENZ Therapeutics, Inc.

CIK 1000275 TORONTO, A6

Position in LENZ

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$871,399

+$180,647 QoQ

Shares Held

95,235

+120.6% QoQ

Ownership

0.304%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 96.99795243345409.ToString("F0")% Shared 0.ToString("F0")% None 3.0020475665459125.ToString("F0")%

Healthcare · as of Mar 31, 2026

ROYAL BANK OF CANADA holds $1,974,323,419 across 406 Biotechnology names. LENZ ranks #60 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,111,871	$496,494,870
2	IONS	Ionis Pharmaceuticals Inc	3,801,815	$285,478,282
3	REGN	Regeneron Pharmaceuticals, Inc.	351,171	$271,328,756
4	ALNY	Alnylam Pharmaceuticals, Inc.	791,515	$261,888,563
5	INCY	Incyte Corp	1,054,123	$99,214,053
6	INSM	INSMED Inc	523,101	$85,537,473
7	MRNA	Moderna, Inc.	999,340	$50,766,470
8	HALO	Halozyme Therapeutics, Inc.	658,290	$42,545,279

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$871,399	95,235	+120.6%	Shares	Defined	2026-05-15
2025-12-31	$690,752	43,172	-10.6%	Shares	Defined	2026-02-17
2025-09-30	$2,249,020	48,283	+78.0%	Shares	Defined	2025-11-14
2025-06-30	$795,062	27,126	+3265.5%	Shares	Defined	2025-11-21
2025-03-31	$20,722	806	-53.4%	Shares	Sole	2025-11-21
2024-12-31	$49,944	1,730	+34.1%	Shares	Defined	2025-02-14
2024-09-30	$30,623	1,290	-3.9%	Shares	Defined	2024-11-14
2024-06-30	$23,202	1,342	+1343.0%	Shares	Defined	2024-11-06
2024-03-31	$2,075	93	—	Shares	Defined	2024-11-05
No filing history on record for this holder in this stock.